Ian Hector Frazer

This inventor holds 24 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Immunotherapy Developments. Top assignees: The University of Queensland, Csl Limited, Admedus Vaccines Pty Ltd.. Active years: 1999-2020. Education: The University of Edinburgh (UK).

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ian Hector Frazer. Retrieved from https://idiyas.com/inventor/ian-hector-frazer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Graduated from:

The University of Edinburgh (UK)

USPTO Granted Patents = 24 (Patent Applications = 4)

% Patents Active = 66.7

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 2.1

ph-index = 6

Forward Citations = 150(Granted Patents)

Location History:

St. Lucia., AU (1999)
Buranda, AU (2005)
St Lucia, AU (2010)
Brisbane, AU (2003 - 2011)
Queensland, AU (2011)
S. Lucia, AU (2014 - 2018)
St. Lucia, AU (1999 - 2020)

Company Filing History:

14 out of 345

The University of Queensland

Admedus Vaccines Pty Ltd.

patents

4. 1 out of 1

Jingang Medicine (Australia) Pty Ltd

patent

5. 1 out of 1

University of the Queensland

patent

6. 5 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2020

Loading Chart...

Areas of Expertise:

Immunomodulating Composition

Papillomavirus Vaccine

Gene Expression System

Codon Translation Efficiency

Synthetic Polynucleotide

Translational Efficiency

Human Papillomavirus Antigens

Nucleic Acid Sequence

Modified Papilloma Virus

Subunit Vaccine

Recombinant Virus

Polyprotein Constructs

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10596248 - Immunomodulating composition for treatment (2020-03-24),

2. 9993542 - Compositions and uses therefor (2018-06-12),

3. 9795658 - Expression system for modulating an immune response (2017-10-24),

4. 9593340 - Expression system for modulating an immune response (2017-03-14),

5. 8858951 - Compositions for eliciting an immune response (2014-10-14),

6. 7939082 - Papilloma virus vaccine (2011-05-10),

7. 7901905 - Gene expression system based on codon translation efficiency (2011-03-08),

8. 7741079 - Method of making a genetically modified mammalian cell (2010-06-22),

9. 7704742 - Method and polynucleotides for determining translational efficiency of a codon (2010-04-27),

10. 7476389 - Papillomavirus vaccines (2009-01-13),

11. 7229761 - Method of constructing a synthetic polynucleotide (2007-06-12),

12. 7172870 - Treatment of papillomavirus infections (2007-02-06),

13. 7169585 - Papillomavirus vaccine (2007-01-30),

14. 6867033 - Treatment of papillomavirus infections (2005-03-15),

15. 6846671 - Method and polynucleotides for determining translational efficiency of a codon (2005-01-25),

Title: Ian Hector Frazer: A Pioneer in HPV Vaccine Development

Introduction

Ian Hector Frazer, a prominent figure in the field of immunology, is based in S. Lucia, Australia. With a remarkable portfolio of 24 patents, his contributions have significantly advanced the understanding and treatment of human papillomavirus (HPV) and other related conditions.

Latest Patents

Frazer's latest patents showcase his innovative approach to immunotherapy. One of his prominent inventions is an immunomodulating composition for treatment that involves therapeutic compositions inducing an immune response to HPV. This patent reveals methods for introducing and expressing a nucleic acid molecule encoding an immunogenic HPV antigen in a subject, aiming to generate a robust immune response.

Another noteworthy patent details the use of a first antigen alongside a second modified antigen that enhances intracellular proteolytic degradation. This invention aims to induce both humoral and cellular immunity, allowing for a dual approach to combatting conditions with long latency periods. Such innovations enhance the capability of immunogenic compositions, combining prophylaxis and therapy in a single delivery.

Career Highlights

Ian Hector Frazer has made significant strides in his career, primarily during his tenure at the University of Queensland, where his research has paved the way for novel vaccine strategies and therapies. His innovative work has attracted attention from various sectors, further solidifying his position as a leading inventor in immunology.

Collaborations

Throughout his career, Frazer has collaborated with several notable individuals, including Jian Zhou and Stirling John Edwards. These partnerships have fostered a dynamic exchange of ideas and research that has contributed to his success and the advancement of immunological studies.

Conclusion

Ian Hector Frazer stands out as a visionary inventor, whose 24 patents reflect his dedication to advancing the fields of immunology and vaccine development. His latest innovations not only enhance our understanding of HPV but also provide new avenues for prevention and treatment, making significant contributions to global health.

Profile summary based on public USPTO records.